Literature DB >> 3207983

Inhibitory actions of amoxapine, a tricyclic antidepressant agent, on electrophysiological properties of mammalian isolated cardiac preparations.

T Kinugawa1, H Kotake, H Mashiba.   

Abstract

1. The electrophysiological effects of amoxapine were examined in guinea-pig isolated papillary muscles and rabbit sinoatrial nodes using a conventional microelectrode technique. 2. In papillary muscles, amoxapine above 10 microM caused a dose-dependent decrease in the maximum upstroke velocity (Vmax) of the action potential and in the action potential amplitude (APA), whereas the action potential duration at 90% repolarization (APD90) was significantly prolonged. For a decrease in Vmax, amoxapine produced a negative shift of the curve relating Vmax to the resting potential (Em) along the voltage axis to more negative membrane potentials. 3. Amoxapine also decreased Vmax and the overshoot potential of K+-depolarized slow action potentials of papillary muscle preparations. 4. In spontaneously beating sinoatrial node preparations, amoxapine above 3 microM reduced the heart rate, Vmax, APA and the slope of phase 4 depolarization in a dose-dependent manner. 5. It was concluded that amoxapine exerts inhibitory actions on fast- and slow-response fibres of the heart and these actions can be mainly explained by inhibition of both fast Na+ and slow Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207983      PMCID: PMC1854089          DOI: 10.1111/j.1476-5381.1988.tb11645.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Characteristics of the rectifying properties of the sino-atrial node cell of the rabbit.

Authors:  I Seyama
Journal:  J Physiol       Date:  1976-02       Impact factor: 5.182

2.  Electronic spread in the sinoatrial node of the rabbit heart.

Authors:  F I Bonke
Journal:  Pflugers Arch       Date:  1973-03-05       Impact factor: 3.657

3.  Effects of dibenzepine and imipramine on the isolated rat heart.

Authors:  A Langslet; W G Johansen; M Ryg; T Skomedal; I Oye
Journal:  Eur J Pharmacol       Date:  1971-05       Impact factor: 4.432

4.  The determination of amoxapine in human fatal overdoses.

Authors:  R L Taylor; C R Crooks; Y H Caplan
Journal:  J Anal Toxicol       Date:  1982 Nov-Dec       Impact factor: 3.367

5.  Electrophysiological effect of disopyramide on rabbit sinus node cells.

Authors:  H Kotake; J Hasegawa; T Hata; H Mashiba
Journal:  J Electrocardiol       Date:  1985-10       Impact factor: 1.438

6.  Isoproterenol inhibits residual fast channel via stimulation of beta-adrenoceptors in guinea-pig ventricular muscle.

Authors:  I Hisatome; T Kiyosue; S Imanishi; M Arita
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

7.  Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy.

Authors:  R B Lydiard; A J Gelenberg
Journal:  Pharmacotherapy       Date:  1981 Nov-Dec       Impact factor: 4.705

8.  The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction.

Authors:  J Vohra; G Burrows; D Hunt; G Sloman
Journal:  Eur J Cardiol       Date:  1975-10

9.  Electrophysiological effects of amoxapine in untreated and in amoxapine-pretreated rat atria.

Authors:  C Delgado; J Manzanares; J Tamargo; C Valenzuela
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

10.  Nature of "residual fast channel" dependent action potentials and slow conduction in guinea pig ventricular muscle and its modification by isoproterenol.

Authors:  M Arita; T Kiyosue; M Aomine; S Imanishi
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

View more
  2 in total

1.  Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine.

Authors:  Sabrina Obers; Ingo Staudacher; Eckhard Ficker; Adrienne Dennis; Ronald Koschny; Hande Erdal; Ramona Bloehs; Jana Kisselbach; Christoph A Karle; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-13       Impact factor: 3.000

Review 2.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.